Distribution of Cyclosporin in Organ Transplant Recipients

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.9, 2002-01, pp. : 615-637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interactions Between Cyclosporin and Lipid-Lowering Drugs: Implications for Organ Transplant Recipients

By åsberg A.

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 367-378

Adis International

Access to resources Recommend Favorite

Tolerogenic immunosuppression for organ transplant recipients

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Therapy for Acute Rejection in Pediatric Organ Transplant Recipients

By Debray D.

Pediatric Drugs, Vol. 5, Iss. 2, 2003-01 ,pp. : 81-93

Adis International

Access to resources Recommend Favorite

Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients

By Belitsky P.

Clinical Pharmacokinetics, Vol. 39, Iss. 2, 2000-08 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Conversion from Cyclosporin to Tacrolimus in Paediatric Liver Transplant Recipients

By Mazariegos G.V.

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 661-672

Adis International

Access to resources Recommend Favorite